MentionFox
Home › funding signals › Cadrenal Therapeutics, Inc.
Company · SEC filings

Cadrenal Therapeutics, Inc. funding history

Cadrenal Therapeutics, Inc. has 6 Form D filings on record, from 2022-12-08 to 2026-07-15. Together its new offerings report $21.16M sold.

Funding historyFounders and team

What do you want to do with Cadrenal Therapeutics, Inc.?

Based
PONTE VEDRA, FLORIDA
Year formed
2022
Industry group
Biotechnology
Filings
6
Raised (new offerings)
$21.16M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-07-15New offering
first sale 2026-06-30
$8.84M$8.84Mdetails · SEC filing
2026-04-06New offering
first sale 2026-04-01
$7.92M$7.92MSEC filing
2025-12-31New offering
first sale 2025-12-16
$4.40M$4.40MSEC filing
2024-11-14Filing——SEC filing
2023-07-18Filing——SEC filing
2022-12-08Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Cadrenal Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/cadrenal-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Cadrenal Therapeutics, Inc. funding history: 6 SEC filings, $21.16M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/cadrenal-therapeutics-inc